Fundraising Fox

Carlos Garcia-Echeverria

Investor

Scientific and Strategic Advisor at Ysios Capital

Spain

About

Dr. Garcia-Echeverria has held senior scientific and executive roles at biopharmaceutical companies including EQRx, Sanofi, and Novartis, with a focus on drug discovery and early-stage clinical development. He currently works as a scientific and strategic advisor to biopharma companies and venture capital firms, advising on drug discovery programs, development strategies, and partnerships. He holds a PhD in organic chemistry from the University of Barcelona and has authored 190 peer-reviewed publications and secured 45 granted patents.

LinkedIn ↗

Invests in

Biotech

Experience

  1. Cancer Research HorizonsMember of the Therapeutic Innovation Boardcurrent2024 — present
  2. GARDOM CONSULTING S.L.Foundercurrent2024 — present
  3. Blueprint MedicinesMember of the Scientific Advisory Board2018 — 2024Cambridge, Massachusetts, United States
  4. EQRxChief of Rx Creation2021 — 2023London, England, United Kingdom
  5. SanofiChief Operating Officer of Research / Global Head of Research Platforms2020 — 2021Paris, Ile-de-France, France
  6. SanofiVP, Global Head of Research Platforms2016 — 2020Paris Area, France
  7. SanofiVP, Global Head of Small Molecule Drug Discovery2014 — 2016Paris Area, France
  8. SanofiDeputy Global Head of Oncology Drug Discovery and Preclinical Research2010 — 2014Vitry-sur-Seine (France)
  9. NovartisExecutive Director - Oncology Drug Discovery Head2005 — 2010Basel Area, Switzerland
  10. NovartisPrograme Team Head - Novartis Leading Scientist1993 — 2005Basel Area, Switzerland

Education

  1. Universitat de BarcelonaDoctor of Philosophy (PhD), Organic Chemistry1987 — 1990
  2. University of Wisconsin-MadisonMedicinal and Pharmaceutical Chemistry1990 — 1993
  3. The George Washington UniversityMaster Certificate in Project Management1999 — 2002
  4. Universitat de BarcelonaLicenciatura degree, Organic Chemistry1986 — 1987
  5. Universitat de BarcelonaLicenciatura, Organic Chemistry1981 — 1986

Skills & more

Drug Discovery51Drug Development21Biotechnology23Medicinal Chemistry32Biochemistry6Biophysical ChemistryBiopharmaceuticals6Pharmacology18Cancer Research4Technology Transfer8Outsourcing1Clinical Development9
+9 moreLife SciencesDrug DesignOncologyCRO ManagementDrug discoveryPharmaceutical IndustryManagementCROIND

From Carlos's professional profile.

Same school

Also attended Universitat de Barcelona88

Andrea AmadorCompliance Manager at Inveready Technology Investment GroupNelson CardonaController at Inveready Technology Investment GroupJosep Maria EcharriManaging Partner & CEO at Inveready Technology Investment GroupMar FernándezMarketing & Communications Manager at Inveready Technology Investment GroupMartina MilàAnalyst at Inveready Technology Investment GroupSara SecallGeneral Partner at Inveready Technology Investment Group

+ 82 more

Also attended University of Wisconsin-Madison174

Zhenyu TangInvestment Director at Intel CapitalDougAdvisor at Clear VenturesDan RuchPartner at Rho VenturesGeorge RobertsInvestor at OpenView Venture PartnersKevin WenzelAssociate at Marlin Equity PartnersSaar GurGeneral Partner at CRV (Charles River Ventures)

+ 168 more

Also attended The George Washington University146

RustyAdvisor at Clear VenturesDonna HoyleVice President & Controller at RevolutionMathew KayeAccounting Manager at RevolutionMeghan FahyDirector of Marketing at GreycroftMaurice RussoInvestor at Lerer HippeauChristina PasanenInvestor at GGV Capital

+ 140 more

Shared employers

Also worked at Cancer Research Horizons1

Genghis Lloyd-HarrisSenior Advisor at Abingworth

Also worked at Blueprint Medicines5

Daniel LynchInvestor at GV (Google Ventures)Deborah PalestrantPartner, Executive Chair, 4:59 Initiative at 5AM VenturesThilo SchroederManaging Partner at Nextech InvestHabib DableAdvisor at RA CapitalChristoph LengauerPartner at Third Rock Ventures

Also worked at Sanofi76

Christine AylwardFounder & Managing Partner at Magnetic VenturesAlan WaltsVenture Partner at Advent Life SciencesMatt VineSenior Associate at RRE VenturesWalter OlesiakOperating Partner at RDiscoveryRamy RiadPresident, Plasma-Derived Therapies Business Unit at Takeda VenturesNigel BrooksbyAdviser at EMV Capital

+ 70 more

Also worked at Novartis105

Rebecca JamesInvestor at Index VenturesScott BillerInvestor at GV (Google Ventures)Freya Svedberg-KeatingInvestor at MedicxiAndrea AmadorCompliance Manager at Inveready Technology Investment GroupAbbie CelnikerInvestor at Third Rock VenturesJesper GromadaInvestor at Third Rock Ventures

+ 99 more

Colleagues at Ysios Capital

Almudena Méndez
Associate at Ysios Capital
Antoni Ribas
Venture Partner at Ysios Capital
Arturo Urrios
Partner at Ysios Capital
Carlos Paya
Venture Partner at Ysios Capital
Catalina Cuchy
Executive Assistant at Ysios Capital
Cristina Garmendia
General Partner at Ysios Capital
David L. Lacey
Venture Partner at Ysios Capital
Guillem Laporta
Partner at Ysios Capital